How BMS Access Support May Help
Find out how BMS can work with patients and their healthcare
providers to help access a prescribed BMS medication.
INDICATIONS
REBLOZYL® (luspatercept-aamt) is a prescription medicine used to treat anemia (low red blood cells) in adults with myelodysplastic syndromes with ring sideroblasts (MDS-RS) or myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) who need regular RBC transfusion and have not responded well to or cannot receive an erythropoiesis stimulating agent (ESA).REBLOZYL is not for use as a substitute for RBC transfusions in people who need immediate treatment for anemia.It is not known if REBLOZYL is safe or effective in children.
REBLOZYL® (luspatercept-aamt) is a prescription medicine used to treat anemia (low red blood cells) in adults with beta thalassemia who need regular red blood cell (RBC) transfusions.REBLOZYL is not for use as a substitute for RBC transfusions in people who need immediate treatment for anemia.It is not known if REBLOZYL is safe or effective in children.
This website is best viewed
using the horizontal display
on your tablet device.
This website is best viewed
using the vertical display on
your mobile device.
One of the best ways to learn about your treatment with REBLOZYL is to talk to your healthcare team. Speaking with your healthcare provider or healthcare team can help make you feel more informed and comfortable. Below are some questions that you may want to ask.
The following organizations provide disease education, additional support, and expert opinions. Inclusion on this list does not indicate endorsement by
American Cancer Society
www.cancer.orgAplastic Anemia and MDS International Foundation
www.aamds.orgCancer Support Community
www.cancersupportcommunity.orgLeukemia & Lymphoma Society
www.lls.org/support/support-groupsLeukemia Research Foundation
www.allbloodcancers.orgMDS Foundation
www.mds-foundation.orgNational Cancer Institute
www.cancer.govBristol Myers Squibb is committed to helping patients gain access to their prescribed BMS medications. That’s why we offer BMS Access Support. BMS Access Support provides resources to help patients understand their insurance coverage. In addition, we can share information on sources of financial support, including co-pay assistance for eligible commercially insured patients.
Find out how BMS can work with patients and their healthcare
providers to help access a prescribed BMS medication.
There may be programs and services that could help with the
cost of treatment. Learn about what options are available.
We provide videos, tools, and other resources that may help
with your access and reimbursement needs.
If you have questions about coverage for a prescribed BMS medication, BMS Access Support may be able to help. Patients and their healthcare provider can complete an enrollment form to learn about programs that may be of assistance. Visit our website or contact BMS Access Support to learn more.
Call Bristol Myers Squibb Access Support at
1-800-861-0048, 8 AM to 8 PM ET, Monday–Friday
Visit www.BMSAccessSupport.com
The accurate completion of reimbursement- or coverage-related documentation is the responsibility of the healthcare provider and the patient. Bristol Myers Squibb and its agents make no guarantee regarding reimbursement for any service or item.
Anemia: Low red blood cell count
Bone marrow: The soft interior of the bones where new blood cells are created
Erythroid cell: An immature red blood cell
Erythroid maturation agent: Treatment that helps young cells become mature cells
Erythropoiesis: The formation of red blood cells in blood-forming tissue within the bone marrow
Erythropoiesis-stimulating agent: A manufactured erythropoietin given to people to help with anemia
Erythropoietin: A natural growth hormone produced by the kidneys that helps make more immature red blood cells
Hemoglobin: Oxygen-carrying protein found in red blood cells
Ineffective erythropoiesis: The inability of immature red blood cells to mature
Intolerant: Unable to take a drug due to effects of the drug or allergies
Median: A statistics term. The middle value in a set of measurements
Mutation: An abnormal change within a gene
Myelodysplastic syndromes (MDS): Derived from myelo, which means marrow, and dysplasia, which means abnormal growth. MDS are a group of disorders in which the bone marrow does not make enough healthy blood cells
MDS/MPN-RS-T: Abbreviation for myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis. It is a rare form of MDS in which there are a high number of platelets in the blood and the immature red blood cells contain ring sideroblasts
Neutropenia: Lower than normal amount of white blood cells
Placebo: An inactive substance that looks the same as, and is given the same way as, an active drug or treatment being tested
Platelet: A type of blood cell that helps with clotting
Prognostic score: A number based on several factors that helps describe the severity of disease or disease progression
Red blood cells (RBCs): Blood cells that carry oxygen from the lungs to all cells in the body
Red blood cell transfusion: A process that adds red blood cells into the bloodstream
Ring sideroblasts: Cells containing rings of iron deposits
Serum: The clear liquid part of the blood that remains after blood cells and clotting proteins have been removed
Subcutaneous: Under the skin
Thrombocytopenia: Lower than normal number of platelets in the blood
Transfusions: Procedures that add parts of blood or whole blood into the bloodstream
White blood cells (WBCs): Blood cells that help the body fight infection as part of the body’s immune system